Australia’s regulator of drugs and medical devices is planning to use artificial intelligence to speed up testing of new medicines already signed off in similar nations, as it comes to grips with shorter drug development lead times. The proposal, which would bring the Therapeutic Goods Administration (TGA) into line with its sister regulator in the…

The post Regulators look to AI for drug approvals, emissions reporting appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.